Hudson Bay Capital Management
CTIC

Hudson Bay Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Hudson Bay Capital Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,500
Closed -$29K – 224
2013
Q4 		$29K Hold
1,500
– – ﹤0.01% 156
2013
Q3 		$25K Buy
+1,500
New +$17.4K ﹤0.01% 169

Other funds holding CTIC

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Hudson Bay Capital Management's CTIC Position: Q1 2014 in Review

Hudson Bay Capital Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q1 2014, closing a stake of 1,500 shares — an estimated $29K sold.

Hudson Bay Capital Management first reported a position in CTIC in Q3 2013 and held it in 2 quarters. The position peaked at $29K in Q4 2013. 93 funds tracked by Wall St. Rank hold CTIC as of Q1 2014.

  • Hudson Bay Capital Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q1 2014 after selling out during the quarter.
  • Hudson Bay Capital Management sold 1,500 CTI BioPharma Corp. (DE) Common Stock shares in Q1 2014, an estimated $29K.
  • Hudson Bay Capital Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2013 and held it in 2 quarters.
  • Hudson Bay Capital Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $29K in Q4 2013.
  • 93 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2014.

Based on Hudson Bay Capital Management's 13F filing for Q1 2014, filed 14 May 2014.